Page 27 - Sciences Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Received $1.0 Million Milestone Payment and Recognized $5.7 Million of License Revenue Under Exclusive License Agreement with 3D Medicines for Development and Commercialization of Galinpepimut-S (GPS) in Greater China National Ethics Committee Approval for GPS Phase 3 REGAL Study Received in Greece Preparations Underway to Activate Clinical Trial Sites and Enroll Patients in the REGAL Study in France, Germany and Greece by End of Second Quarter 2021 NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a late-stage clin...

/PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in...

Author Bio Sushree is a new member of the Fool family, keen on writing about the cannabis and healthcare sector and also has five years of experience writing on real estate, consumer sector, and macroeconomic topics. She holds a bachelor’s degree in business management, specializing in finance, and also a CFA Level 2 candidate. Being a fitness enthusiast and a creative person, when she isn't writing, she is either kick-boxing or painting. The coronavirus pandemic that wreaked havoc on most sectors globally has spared the marijuana industry. Cannabis sales spiked amid...

Share: TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (" Yooma") (CSE:YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has filed the annual financial statements (the " Financial Statements") for one of its predecessor companies, Yooma Corp., for the financial period from January 1, 2020 to December 31, 2020 (the " Reporting Period"). Yooma was formed by amalgamation on February 10, 2021, when Yooma Corp. completed a reverse takeover of Globalive Technology Inc. (" GTI"). ...

Share this article Share this article NEW YORK, April 22, 2021 /PRNewswire/ -- Cancer research and development are a major part of the biotechnology industry, and there is always room for improvement and growth. Recently, biotech company Perimeter Medical Imaging Al (TSXV: PINK) (OTC: PYNKF) revealed a revolutionary way for surgeons to be able to assess if a cancer has been fully removed, while still in the operating room. Syndax Pharmaceuticals (NASDAQ: SNDX), Nektar Therapeutics (NASDAQ: NKTR), SELLAS Life Sciences Group (NASDAQ: SLS), and Celldex Therapeutics (NASDAQ: CLDX) are also l...